| 000 | 01709 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516054944.0 | ||
| 264 | 0 | _c20111222 | |
| 008 | 201112s 0 0 eng d | ||
| 022 | _a1527-7755 | ||
| 024 | 7 |
_a10.1200/JCO.2011.36.8134 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDomchek, Susan M | |
| 245 | 0 | 0 |
_aChallenges to the development of new agents for molecularly defined patient subsets: lessons from BRCA1/2-associated breast cancer. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cNov 2011 |
||
| 300 |
_a4224-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenes, BRCA1 |
| 650 | 0 | 4 | _aGenes, BRCA2 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPoly(ADP-ribose) Polymerase Inhibitors |
| 650 | 0 | 4 | _aResearch Design |
| 700 | 1 | _aMitchell, Gillian | |
| 700 | 1 | _aLindeman, Geoffrey J | |
| 700 | 1 | _aTung, Nadine M | |
| 700 | 1 | _aBalmaña, Judith | |
| 700 | 1 | _aIsakoff, Steven J | |
| 700 | 1 | _aSchmutzler, Rita | |
| 700 | 1 | _aAudeh, M William | |
| 700 | 1 | _aLoman, Niklas | |
| 700 | 1 | _aScott, Clare | |
| 700 | 1 | _aFriedlander, Michael | |
| 700 | 1 | _aKaufman, Bella | |
| 700 | 1 | _aGarber, Judy E | |
| 700 | 1 | _aTutt, Andrew | |
| 700 | 1 | _aRobson, Mark E | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 29 _gno. 32 _gp. 4224-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2011.36.8134 _zAvailable from publisher's website |
| 999 |
_c21169511 _d21169511 |
||